Table 1 Anthropometric and clinical characteristics of participants included in the screening phase of the study.
From: Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity
Variable | Overall (n = 20) | MHO (n = 10) | MAO (n = 10) | P-value¥ | |||
|---|---|---|---|---|---|---|---|
Mean (Std. Dev) | Range (Min - Max) | Mean (Std. Dev) | Range (Min - Max) | Mean (Std. Dev) | Range (Min - Max) | ||
AGE (Years) | 42.30 (8.85) | 30.00–59.00 | 41.30 (10.08) | 30.00–58.00 | 43.30 (7.85) | 31.00–59.00 | 0.6265 |
BMI (Kg/m2) | 40.62 (10.62) | 31.13–70.32 | 36.49 (5.69) | 31.16–48.67 | 44.75 (12.95) | 31.13–70.32 | 0.0892 |
WHR | 0.86 (0.07) | 0.71–0.98 | 0.82 (0.06) | 0.71–0.91 | 0.90 (0.05) | 0.84–0.98 | 0.0042* |
SBPS (mmHg) | 131.98 (22.74) | 105.00–195.00 | 118.20 (6.32) | 105.00–125.50 | 145.75 (25.11) | 113.00–195.00 | 0.0071* |
DBPS (mmHg) | 80.08 (11.87) | 67.00–109.00 | 73.75 (4.78) | 67.00–81.00 | 86.40 (13.63) | 67.50–109.00 | 0.018* |
Glucose (mg/dl) | 93.18 (15.33) | 78.00–124.50 | 83.35 (4.50) | 78.00–91.00 | 103.00 (16.17) | 81.50–124.50 | 0.0038* |
Log10HOMA-IR | 0.65 (0.52) | −0.09–1.93 | 0.22 (0.22) | −0.09–0.51 | 1.08 (0.32) | 0.83–1.93 | <0.0001* |
Geometric mean | 4.47 | 1.66 | 12.09 | ||||
TG/HDL-C | 2.26 (3.87) | 0.39–16.95 | 0.59 (0.25) | 0.39–1.18 | 3.92 (5.04) | 0.93–16.95 | 0.066 |
Log10CRP(mg/dl) | −0.32 (0.63) | −1.22–0.68 | −0.86 (0.24) | −1.22–0.54 | 0.22 (0.37) | −0.40–0.68 | <0.0001* |
Geometric mean | 0.48 | 0.14 | 1.66 | ||||
